Under what condition is a pharmacy not required to communicate the biologic product information to the prescriber?

A pharmacy is not required to communicate the biologic product information to the prescriber if the same product is dispensed upon refill. This is important because if a patient is receiving a refill of a medication that is the same as what they have previously been prescribed, there is typically no need for the pharmacy to inform the prescriber again about the specifics of that product. This minimizes unnecessary communication and administrative burdens when continuity of care is maintained with the same product.

In situations where the pharmacy dispenses a different product—particularly in the case of interchangeable biologics—it is vital to communicate with the prescriber to ensure that the treatment plan remains aligned with the prescriber's intentions. Therefore, if the patient maintains consistency with their original biologic product, it supports seamless patient care without requiring additional updates to the prescriber.